×
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
NYSE:SYK

Stryker (SYK) Stock Forecast, Price & News

$236.50
+1.56 (+0.66%)
(As of 05/27/2022 12:00 AM ET)
Add
Compare
Today's Range
$236.17
$238.57
50-Day Range
$226.72
$276.37
52-Week Range
$224.02
$281.16
Volume
1.02 million shs
Average Volume
1.50 million shs
Market Capitalization
$89.43 billion
P/E Ratio
44.96
Dividend Yield
1.18%
Beta
0.99
30 days | 90 days | 365 days | Advanced Chart
Receive SYK News and Ratings via Email

Sign-up to receive the latest news and ratings for Stryker and its competitors with MarketBeat's FREE daily newsletter.

Stryker logo

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Headlines

Stryker (NYSE:SYK) Price Target Cut to $280.00
Stryker (NYSE:SYK) Cut to "C+" at TheStreet
See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
86366710
Employees
46,000
Year Founded
1941

Sales & Book Value

Annual Sales
$17.11 billion
Cash Flow
$12.13 per share
Book Value
$39.79 per share

Profitability

Net Income
$1.99 billion
Pretax Margin
13.20%

Debt

Price-To-Earnings

Miscellaneous

Free Float
352,818,000
Market Cap
$89.43 billion
Optionable
Optionable

Company Calendar

Ex-Dividend for 4/29 Dividend
3/30/2022
Last Earnings
4/28/2022
Dividend Payable
4/29/2022
Today
5/27/2022
Next Earnings (Estimated)
7/26/2022
Fiscal Year End
12/31/2022

Social Links


MarketRank

Overall MarketRank

2.79 out of 5 stars

Medical Sector

36th out of 1,424 stocks

Surgical & Medical Instruments Industry

5th out of 137 stocks

Analyst Opinion: 2.3Community Rank: 4.5Dividend Strength: 4.2Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -













Stryker (NYSE:SYK) Frequently Asked Questions

Is Stryker a buy right now?

18 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last year. There are currently 6 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Stryker stock.
View analyst ratings for Stryker
or view top-rated stocks.

When is Stryker's next earnings date?

Stryker is scheduled to release its next quarterly earnings announcement on Tuesday, July 26th 2022.
View our earnings forecast for Stryker
.

How were Stryker's earnings last quarter?

Stryker Co. (NYSE:SYK) posted its quarterly earnings results on Thursday, April, 28th. The medical technology company reported $1.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.93 by $0.04. The medical technology company had revenue of $4.30 billion for the quarter, compared to analyst estimates of $4.19 billion. Stryker had a net margin of 11.56% and a trailing twelve-month return on equity of 24.09%. The business's quarterly revenue was up 8.8% on a year-over-year basis. During the same period last year, the business posted $1.93 EPS.
View Stryker's earnings history
.

How often does Stryker pay dividends? What is the dividend yield for Stryker?

Stryker announced a quarterly dividend on Wednesday, May 4th. Shareholders of record on Thursday, June 30th will be paid a dividend of $0.695 per share on Friday, July 29th. This represents a $2.78 dividend on an annualized basis and a dividend yield of 1.18%. The ex-dividend date of this dividend is Wednesday, June 29th.
View Stryker's dividend history
.

Is Stryker a good dividend stock?

Stryker pays an annual dividend of $2.78 per share and currently has a dividend yield of 1.18%. Stryker has been increasing its dividend for 29 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Stryker is 52.85%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Stryker will have a dividend payout ratio of 25.84% next year. This indicates that Stryker will be able to sustain or increase its dividend.
View Stryker's dividend history.

What guidance has Stryker issued on next quarter's earnings?

Stryker issued an update on its FY 2022 earnings guidance on Monday, May, 9th. The company provided earnings per share guidance of $9.60-$9.60 for the period, compared to the consensus EPS estimate of $9.76. The company issued revenue guidance of -.

What price target have analysts set for SYK?

18 analysts have issued 1 year target prices for Stryker's stock. Their forecasts range from $275.00 to $320.00. On average, they anticipate Stryker's stock price to reach $292.00 in the next year. This suggests a possible upside of 23.5% from the stock's current price.
View analysts' price targets for Stryker
or view top-rated stocks among Wall Street analysts.

Who are Stryker's key executives?
Stryker's management team includes the following people:
  • Mr. Kevin A. Lobo, Chairman, CEO & Pres (Age 57, Pay $3.59M) (LinkedIn Profile)
  • Mr. Glenn S. Boehnlein, VP & CFO (Age 60, Pay $1.46M)
  • Mr. Timothy John Scannell, Exec. Advisor (Age 57, Pay $1.74M) (LinkedIn Profile)
  • Mr. Viju S. Menon, Group Pres of Global Quality & Operations (Age 54, Pay $1.08M)
  • Mr. J. Andrew Pierce, Group Pres of MedSurg & Neurotechnology (Age 48, Pay $1.41M)
  • Mr. Spencer S. Stiles, Group Pres of Orthopaedics & Spine (Age 45, Pay $1.33M)
  • Mr. William E. Berry Jr., VP & Chief Accounting Officer (Age 56)
  • Mr. Robert C. Cohen, CTO and VP of Global R&D - Joint Replacement
  • Mr. Alan Douville, VP, Chief Information Officer & Chief Information Security Officer
  • Mr. Preston Wells, VP of Investor Relations
What is Kevin A. Lobo's approval rating as Stryker's CEO?

1,492 employees have rated Stryker CEO Kevin A. Lobo on Glassdoor.com. Kevin A. Lobo has an approval rating of 97% among Stryker's employees. This puts Kevin A. Lobo in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Stryker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Johnson & Johnson (JNJ), Walt Disney (DIS), Home Depot (HD), Medtronic (MDT), Visa (V), AbbVie (ABBV), Cisco Systems (CSCO), Intel (INTC), QUALCOMM (QCOM) and NVIDIA (NVDA).

What is Stryker's stock symbol?

Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."

Who are Stryker's major shareholders?

Stryker's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (7.64%), BlackRock Inc. (6.18%), Greenleaf Trust (5.31%), Wellington Management Group LLP (4.06%), State Street Corp (3.65%) and Capital Research Global Investors (2.75%). Company insiders that own Stryker stock include Allan C Golston, Glenn S Boehnlein, Kevin Lobo, M Kathryn Fink, Robert S Fletcher, Roch Doliveux, Ronda E Stryker, Srikant M Datar and Timothy J Scannell.
View institutional ownership trends for Stryker
.

Which institutional investors are selling Stryker stock?

SYK stock was sold by a variety of institutional investors in the last quarter, including WCM Investment Management LLC, Massachusetts Financial Services Co. MA, First Trust Advisors LP, Carmignac Gestion, BlackRock Inc., American Century Companies Inc., Neuberger Berman Group LLC, and Canada Pension Plan Investment Board. Company insiders that have sold Stryker company stock in the last year include Glenn S Boehnlein, Robert S Fletcher, Ronda E Stryker, and Srikant M Datar.
View insider buying and selling activity for Stryker
or view top insider-selling stocks.

Which institutional investors are buying Stryker stock?

SYK stock was purchased by a variety of institutional investors in the last quarter, including First Western Trust Bank, Ontario Teachers Pension Plan Board, Wellington Management Group LLP, AustralianSuper Pty Ltd, Capital Research Global Investors, Arrowstreet Capital Limited Partnership, Alyeska Investment Group L.P., and Clearbridge Investments LLC.
View insider buying and selling activity for Stryker
or or view top insider-buying stocks.

How do I buy shares of Stryker?

Shares of SYK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Stryker's stock price today?

One share of SYK stock can currently be purchased for approximately $236.50.

How much money does Stryker make?

Stryker has a market capitalization of $89.43 billion and generates $17.11 billion in revenue each year. The medical technology company earns $1.99 billion in net income (profit) each year or $5.26 on an earnings per share basis.

How many employees does Stryker have?

Stryker employs 46,000 workers across the globe.

Does Stryker have any subsidiaries?

The following companies are subsidiares of Stryker: 2Hip Holdings SAS, ActiViews, Aimago SA, Alcott Indemnity Company, Arrinex Inc., Ascent Healthcare Solutions, Berchtold, Berchtold + Fritz GmbH, Berchtold Consulting GmbH, Berchtold Corporation, Berchtold GmbH & Co. KG, Berchtold Holding Switzerland GmbH, BioMimetic Therapeutics LLC, BioMimetic Therapeutics USA Inc., CHG Hospital Beds, Cactus LLC, Cardan Robotics, Cartiva Inc., Changzhou Orthomed Medical Instrument Company Limited, Concentric Medical, EnMovi Ltd., Entellus Medical, Entellus Medical Inc., GYS Tech LLC, Gauss Surgical, Gauss Surgical Inc., Gauss Surgical Singapore Pte. Ltd., Gaymar Industries, Gongping (Shanghai) Medical Devices Trading Co. Ltd., Groupe Bertec, HeartSine Technologies LLC, HeartSine Technologies Limited, Howmedica International S. de R.L., Howmedica Osteonics Corp., Hygia Health Services, Hygia Healthcare Services Inc., HyperBranch, HyperBranch Medical Technologies Inc., HyperBranch Medical Technology, Image Guided Technologies, Imascap SAS, Imorphics Limited, Infinity MSD Corp., Infinity MSF Corp., Infomedix Communications, Instratek, InstruMedics L.L.C, Invuity, Invuity Inc., Ivy Sports Medicine, Ivy Sports Medicine LLC, Jiangsu Chuangyi Medical Instrument Company Limited, Jolife AB, K2M Group, K2M Group Holdings Inc., K2M Holdings Inc., K2M Inc., K2M UK Limited, Loon Intermediateco LLC, MAKO Surgical, MAKO Surgical Corp, Memometal Technologies, Mobius Imaging, Mobius Imaging LLC, Muka Metal, Muka Metal Ticaret ve Sanayi Anaonim Sirketi, NV Stryker SA, Nettrick Limited, Novadaq Corp, Novadaq Technologies, Novadaq Technologies ULC, OOO "Stryker", Orneo Özel Sağlık Hizmetleri Medikal Ticaret Anonim Şirketi, Ortho-Space Ltd., OrthoHelix Surgical Designs Inc., OrthoSensor, OrthoSensor Korea Ltd, OrthoSpace, OrthoSpace US Inc., Orthomed (Hong Kong) Medical Instrument Company Limited, Orthosensor Inc., Orthovita, Orthovita Inc., OtisMed, P.C. Sweden Holding AB, PTH West LLC, Patient Safety Technologies, Patton Surgical, Physio-Control, Physio-Control (Shanghai) Sales Co. Ltd., Physio-Control Brazil Vendas Ltda., Physio-Control Holdings Coöperatief U.A., Physio-Control Holdings Inc, Physio-Control Inc., Physio-Control Investments LLC, Physio-Control Lebanon Sales Offshore s.a.l., Physio-Control Manufacturing Inc., Physio-Control Operations Netherlands B.V., Physio-Control Sales Limited Liability Company, Pivot Medical, PlasmaSol, Porex Technologies, SCI Calyx SA, SSI Divestiture Inc., SYK Costa Rica Services Sociedad De Responsabilidad Limitada, SafeAir AG, SafeWire, Sage Products, Sage Products Coӧperatief U.A., Sage Products Holdings II LLC, Sage Products Holdings III LLC, Sage Products LLC, Scopis, Scopis GmbH, Sightline Technologies, Small Bone Innovations, SpineCore, Spirox Inc., Stanmore Implants Worldwide, Stanmore Implants Worldwide Limited, Stanmore Inc., Stryker (Barbados) Foreign Sales Corporation, Stryker (Beijing) Healthcare Products Co. Ltd., Stryker (Shanghai) Healthcare Products Co. Ltd., Stryker (Suzhou) Medical Technology Co Ltd, Stryker (Thailand) Limited, Stryker AB, Stryker Acquisitions B.V., Stryker Asia Holdings C.V., Stryker Australia LLC, Stryker Australia Pty. Ltd., Stryker Austria GmbH, Stryker B.V., Stryker Berchtold B.V., Stryker Beteiligungs GmbH, Stryker Canada Holding Company ULC, Stryker Canada Manufacturing ULC, Stryker Canada ULC, Stryker Canadian Management ULC, Stryker Capital B.V., Stryker China Limited, Stryker Colombia SAS, Stryker Communications Inc., Stryker Corporation (Chile) y Compania Limitada, Stryker Corporation (Malaysia) Sdn. Bhd., Stryker Customs Brokers LLC, Stryker Czech Republic s.r.o., Stryker Delaware Inc., Stryker EMEA Supply Chain Services B.V., Stryker Employment Company LLC, Stryker European Holdings Coöperatief U.A, Stryker European Holdings LLC, Stryker European Operations B.V., Stryker European Operations Holdings I B.V., Stryker European Operations Holdings II B.V., Stryker European Operations Holdings III B.V., Stryker European Operations Holdings LLC, Stryker European Operations Limited, Stryker Far East Inc., Stryker Foreign Acquisitions Inc., Stryker France SAS, Stryker Funding B.V., Stryker Global Technology Center Private Limited, Stryker GmbH, Stryker GmbH & Co. KG, Stryker Grundstücks GmbH & Co KG, Stryker Grundstücks Verwaltungs GmbH, Stryker Holdings B.V., Stryker IFSC Designated Activity Company, Stryker Iberia S.L. Unipersonal, Stryker India Private Limited, Stryker International Acquisitions B.V., Stryker International Holdings B.V., Stryker Ireland Limited, Stryker Italia S.r.l., Stryker Japan K.K., Stryker Korea Ltd., Stryker Lebanon (Offshore) S.A.L., Stryker Leibinger GmbH & Co. KG, Stryker Luxembourg Sarl, Stryker Malta Holdings Limited, Stryker Manufacturing Holdings B.V., Stryker Manufacturing S. de R.L. de C.V., Stryker Mauritius Holding Ltd., Stryker Medical London LP, Stryker Medtech K.K., Stryker Medtech Limited, Stryker Mexico Holdings B.V., Stryker Mexico SA de CV, Stryker NV Operations Limited, Stryker Nederland B.V., Stryker New Zealand Limited, Stryker Osteonics AG, Stryker Pacific Limited, Stryker Performance Solutions LLC, Stryker Poland Services sp. z o.o., Stryker Polska Sp.z.o.o., Stryker Portugal - Produtos Medicos Unipessoal Lda., Stryker Professional Latin America S. de R.L. de C.V., Stryker Puerto Rico Holdings B.V., Stryker Puerto Rico LLC, Stryker Puerto Rico Sales LLC, Stryker Renovation Services LLC, Stryker Romania SRL, Stryker Sales LLC, Stryker Servicios Administrativos S.de R.L. de C.V., Stryker Singapore Private Limited, Stryker South Africa (Proprietary) Limited, Stryker Spine SAS, Stryker Spine Sarl, Stryker Sustainability Solutions Inc., Stryker Tibbi Cihazlan Sanayi ve Ticaret Limited Sirketi, Stryker Tijuana Operations S. de R.L. de C.V., Stryker Trauma GmbH, Stryker Turkish Holdings B.V., Stryker UK Limited, Stryker Unite Ltd., Stryker Verwaltungs GmbH, Stryker Vietnam Company Limited, Stryker do Brasil Ltda, Surpass Medical, Synergetics, TMG France SAS, TMJ Solutions LLC, TSO3 Corporation, TSO3 Inc., Thermedx LLC, Tornier Inc., Tornier Orthopedics Ireland Limited, Tornier Pty Ltd., Tornier SAS, Tornier Scandinavia A/S, Tornier UK Limited, Tornier US Holdings Inc., Trauson, Trauson (China) Medical Instrument Company Limited, Trauson (Hong Kong) Company Limited, Trauson Holdings (B.V.I.) Company Limited, Trauson Holdings (Hong Kong) Company Limited, Trauson Holdings Company Limited, Trooper Holdings Inc., Vexim, Vocera, Vocera Communications, Wright DutchCo B.V., Wright Medical Australia Pty Limited, Wright Medical Brasil Ltda, Wright Medical Costa Rica S.A., Wright Medical Device (Shanghai) Co. Ltd., Wright Medical Group, Wright Medical Group Inc., Wright Medical Netherlands B.V., Wright Medical Singapore Pte Ltd, Wright Medical Technology Inc., Wright Medical UK Ltd, Wright PacRim Inc., ZipLine Medical Consulting (Shanghai) Co. Ltd., ZipLine Medical Hong Kong Limited, ZipLine Medical Inc., and eTrauma.com.

When was Stryker founded?

Stryker was founded in 1941.

What is Stryker's official website?

The official website for Stryker is www.strykercorp.com.

How can I contact Stryker?

Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company can be reached via phone at (269) 385-2600, via email at [email protected], or via fax at 269-385-1062.

This page was last updated on 5/28/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.